SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-160097"
 

Search: onr:"swepub:oai:DiVA.org:uu-160097" > Antibodies against ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Antibodies against alpha-synuclein reduce oligomerization in living cells

Näsström, Thomas (author)
Uppsala universitet,Geriatrik,Lannfelt, Molekylär geriatrik/ Rudbecklaboratoriet
Goncalves, Susana (author)
Cell and Molecular Neuroscience Unit, Instituto de Medicina Molecular, Lisboa
Sahlin, Charlotte (author)
Uppsala universitet,Geriatrik
show more...
Nordström, Eva (author)
BioArctic Neuroscience AB
Screpanti Sundquist, Valentina (author)
BioArctic Neuroscience AB
Lannfelt, Lars (author)
Uppsala universitet,Geriatrik,Lannfelt, Molekylär geriatrik/ Rudbecklaboratoriet
Bergström, Joakim (author)
Uppsala universitet,Geriatrik,Lannfelt, Molekylär geriatrik/ Rudbecklaboratoriet
Outeiro, Tiago. F (author)
Cell and Molecular Neuroscience Unit, Instituto de Medicina Molecular, Lisboa. Instituto de Fisiologia, Faculdade de Medicina da Universidade de Lisboa, Lisboa. Department of NeuroDegeneration and Restaurative Research, Universitätsmedizin Göttingen, Göttingen
Ingelsson, Martin (author)
Uppsala universitet,Geriatrik,Lannfelt, Molekylär geriatrik/ Rudbecklaboratoriet
show less...
 (creator_code:org_t)
2011-10-31
2011
English.
In: PLOS ONE. - : Public Library of Science (PLoS). - 1932-6203. ; 6:10, s. e27230-
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Recent research implicates soluble aggregated forms of α-synuclein as neurotoxic species with a central role in the pathogenesis of Parkinson’s disease and related disorders. The pathway by which α-synuclein aggregates is believed to follow a step-wise pattern, in which dimers and smaller oligomers are initially formed. Here, we used H4 neuroglioma cells expressing α-synuclein fused to hemi:GFP to study the effects of α-synuclein monoclonal antibodies on the early stages of aggregation, as quantified by Bimolecular Fluorescence Complementation assay. Widefield and confocal microscopy revealed that cells treated for 48 h with monoclonal antibodies internalized antibodies to various degrees. Oligomer-selective and C-terminal specific α-synuclein antibodies reduced the extent of α-synuclein dimerization/oligomerization, as indicated by decreased GFP fluorescence signal. Furthermore, ELISA measurements on lysates and conditioned media from antibody treated cells displayed lower α-synuclein levels compared to untreated cells, suggesting increased protein turnover. Taken together, our results propose that extracellular administration of monoclonal antibodies can modify or inhibit early steps in the aggregation process of α-synuclein, thus providing further support for passive immunization against diseases with α-synuclein pathology.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Neurosciences (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Cell- och molekylärbiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Cell and Molecular Biology (hsv//eng)

Keyword

Alpha-synuclein; Parkinson’s disease; Lewy bodies; Aggregation; Bimolecular Fluorescence Complementation; Monoclonal antibodies; Immunotherapy
Neuroscience
Neurovetenskap
Geriatrics
Geriatrik

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

  • PLOS ONE (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view